"Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H2 2012" - New Market Report
Global Markets Direct's, 'Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ). Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, Half...
View full press release